GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » OnKure Therapeutics Inc (NAS:OKUR) » Definitions » Float Percentage Of Total Shares Outstanding

OKUR (OnKure Therapeutics) Float Percentage Of Total Shares Outstanding : 70.23% (As of Apr. 26, 2025)


View and export this data going back to 2024. Start your Free Trial

What is OnKure Therapeutics Float Percentage Of Total Shares Outstanding?

Float percentage of total shares outstanding is the percentage of float shares relative to the total shares outstanding. As of today, OnKure Therapeutics's float shares is 9.44 Mil. OnKure Therapeutics's total shares outstanding is 13.44 Mil. OnKure Therapeutics's float percentage of total shares outstanding is 70.23%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, OnKure Therapeutics's Insider Ownership is 0.95%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, OnKure Therapeutics's Institutional Ownership is 88.70%.

OnKure Therapeutics Float Percentage Of Total Shares Outstanding Calculation

It is the percentage of float shares out of the total shares outstanding.

OnKure Therapeutics's Float Percentage of Total Shares Outstanding for today is calculated as follows:

Float Percentage of Total Shares Outstanding=Float Shares/Total Shares Outstanding
=9.44/13.44
=70.23%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

OnKure Therapeutics Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » OnKure Therapeutics Inc (NAS:OKUR) » Definitions » Float Percentage Of Total Shares Outstanding
Comparable Companies
APLT QNCX GUTS INZY IMRX CNTX ANRO CYCC CUE STRO VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX ALNY XBRU:UCB ONC XKRX:068270 BNTX
Traded in Other Exchanges
N/A
Address
6707 Winchester Circle, Suite 400, Boulder, CO, USA, 80301
Website
https://www.onkuretherapeutics.com
OnKure Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing top-tier precision medicines that target biologically validated drivers of cancers that are underserved by available therapies. The company operates in one operating segment which is clinical research. It has a pipeline of tumor-agnostic candidates that are designed to achieve optimal efficacy and tolerability.